Acquisitions29 Sept 2025, 01:26 pm
Entero Healthcare to Sell Suprabhat, Acquire 60% Stake in Ace Cardiopathy
AI Summary
Entero Healthcare Solutions Ltd announced the outcome of its Board meeting held on September 29, 2025. The Board approved the sale of the entire stake (100%) in Suprabhat Pharmaceutical Private Limited, a wholly owned subsidiary of the Company. Additionally, the Board approved the acquisition of 60% stake in Ace Cardiopathy Solutions Private Limited, subject to satisfactory completion of due diligence and execution of definitive agreements.
Key Highlights
- Entero Healthcare to sell entire stake in Suprabhat Pharmaceutical Private Limited
- Approval to acquire 60% stake in Ace Cardiopathy Solutions Private Limited
- Transaction value for Ace Cardiopathy acquisition to range between INR 59.30 Crore to INR 77.10 Crore
- Suprabhat Pharmaceutical Private Limited is a wholly owned subsidiary of Entero Healthcare
- Ace Cardiopathy Solutions Private Limited operates in the same industry as Entero Healthcare